Monoacylglycerol Lipase Inhibitor JZL184 Improves Behavior and Neural Properties in Ts65Dn Mice, a Model of Down Syndrome-Reference-Cited by-同舟云学术

Monoacylglycerol Lipase Inhibitor JZL184 Improves Behavior and Neural Properties in Ts65Dn Mice, a Model of Down Syndrome

Published:2014-12-04 Issue:12 Volume:9 Page:e114521
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lysenko Larisa V.,Kim Jeesun,Henry Cassandra,Tyrtyshnaia Anna,Kohnz Rebecca A.,Madamba Francisco,Simon Gabriel M.,Kleschevnikova Natalia E.,Nomura Daniel K.,Ezekowitz R . Alan B.,Kleschevnikov Alexander M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference87 articles.

1. Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids;A Luchicchi;Mol Neurobiol,2012

2. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol;JL Blankman;Chem Biol,2007

3. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system;JE Schlosburg;Nat Neurosci,2010

4. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects;JZ Long;Nat Chem Biol,2009

5. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation;DK Nomura;Science,2011

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dissection of a Down syndrome-associated trisomy to separate the gene dosage-dependent and -independent effects of an extra chromosome;Human Molecular Genetics;2023-04-04

2. Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases;Pharmacology & Therapeutics;2023-04

3. The monoacylglycerol lipase inhibitor, JZL184, has comparable effects to therapeutic hypothermia, attenuating global cerebral injury in a rat model of cardiac arrest;Biomedicine & Pharmacotherapy;2022-12

4. GIRK2 Channels in Down Syndrome and Alzheimer’s Disease;Current Alzheimer Research;2022-10

5. Brain circuit pathology in Down syndrome: from neurons to neural networks;Reviews in the Neurosciences;2022-09-29